Brief: Inari Medical Announces In-Hospital And 30-Day Outcomes From The Fully Enrolled Clout Registry And Results From Propensity-Score Matched Comparison Of Clout Versus. Attract
Oct 31 (Reuters) - Inari Medical Inc NARI.O :
* INARI MEDICAL ANNOUNCES IN-HOSPITAL AND 30-DAY OUTCOMES
FROM THE
FULLY ENROLLED CLOUT REGISTRY AND RESULTS FROM PROPENSITY-SCORE
MATCHED COMPARISON OF CLOUT VERSUS. ATTRACT
* INARI MEDICAL - OVER 90% MET PRIMARY ENDPOINT OF STUDY &
THERE
WAS ONLY ONE DEVICE-RELATED SERIOUS ADVERSE EVENT
* INARI MEDICAL INC - NO REPORTS OF VALVE DAMAGE, VESSEL
DAMAGE,
OR ACUTE KIDNEY INJURY IN STUDY
Source text for Eikon: ID:nGNXbFPDNK
Further company coverage: NARI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inari Medical
See all newsJ&J explores bid for Intra-Cellular Therapies, Bloomberg News reports (updated)
U.S. RESEARCH ROUNDUP-GE Healthcare, Summit Materials, Tapestry
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty